Risk factors for recurrence of intussusception in pediatric patients: A retrospective study

Xiaolong Xie, Yang Wu, Qi Wang

  • 1Department of pediatric surgery, West China hospital, Sichuan University, China.

Insights

Children aged two and older, prolonged symptoms over 48 hours, rectal bleeding, left-sided mass location, and pathological lead points increase intussusception recurrence risk. These factors aid in predicting outcomes after treatment.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Clinical Epidemiology

Background:

  • Intussusception is a common surgical emergency in children.
  • Recurrence after initial reduction poses clinical challenges.
  • Identifying risk factors for recurrence is crucial for patient management.

Purpose of the Study:

  • To investigate risk factors for intussusception recurrence.
  • To analyze predictors of recurrence after operative and nonoperative reduction.
  • To inform clinical decision-making and prognostic assessments.

Main Methods:

  • Retrospective analysis of pediatric patients with intussusception (2004-2012).
  • Inclusion of patients aged 0-18 years undergoing initial reduction (nonoperative or operative).
  • Data collection included demographics, symptoms, signs, ultrasound findings, and reduction method.

Main Results:

  • Multivariable analysis identified significant risk factors for recurrence.
  • Age ≥ 2 years (OR=5.597), duration of symptoms ≥ 48h (OR=91.664), and rectal bleeding (OR=4.758) were key predictors.
  • Left-sided mass location (OR=0.038) and pathological lead point (OR=0.002) also significantly influenced recurrence risk.

Conclusions:

  • Age, symptom duration, rectal bleeding, mass location, and pathological lead point are significant risk factors for intussusception recurrence.
  • These findings can help stratify risk and guide follow-up strategies.
  • Further research may explore specific interventions based on these identified risk factors.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
310
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
338